F16.98
Hallucinogen use, unspecified with other specified hallucinogen-induced disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F16.98 refers to the use of hallucinogens, unspecified, combined with other specified hallucinogen-induced disorders. Hallucinogens are a class of drugs that alter perception, mood, and various cognitive processes. These substances can lead to a range of mental health issues, especially when used improperly or excessively. This guide provides an overview of hallucinogen use, associated disorders, causes, symptoms, diagnosis, and treatment options to help readers better understand this complex subject.
Causes & Symptoms
Clinical Causes: Experimentation with psychoactive substances for recreational purposes Peer influence or social environment encouraging drug use Mental health conditions that increase vulnerability to substance use Seeking spiritual or mystical experiences Relief from psychological distress or trauma
Key Symptoms: Hallucinations, including visual or auditory distortions Altered perceptions of reality Dizziness or loss of coordination Changes in mood, such as euphoria or anxiety Paranoia or suspiciousness Confusion or disorientation Rapid shifts in perception and thought processes Physical symptoms like increased heart rate, dilated pupils, and sweating
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hallucinogen-induced disorders involves comprehensive clinical assessments by healthcare professionals. The process includes evaluating the patient's history of drug use, observing current symptoms, and ruling out other mental health conditions. Laboratory tests like urine or blood screenings may detect the presence of hallucinogens or their metabolites. Mental status examinations and psychiatric evaluations help determine the impact on cognitive functioning and emotional well-being. The diagnostic criteria also consider the duration and severity of symptoms and their correlation with recent drug use.
Treatment Protocols: Psychological therapies such as cognitive-behavioral therapy (CBT) to address underlying issues and prevent relapse Monitoring and managing acute symptoms in a medical setting, including agitation or psychosis Providing a safe environment to reduce harmful behaviors during episodes Addressing co-occurring mental health conditions like depression or anxiety Long-term substance abuse counseling and support groups
Clinical Advice & FAQs
Billing Guidance
Is F16.98 a billable ICD-10 code?
Yes, F16.98 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.98?
Clinical documentation must specify the nature of Hallucinogen use, unspecified with other specified hallucinogen-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference